BQCIS

Ensuring Regulatory Compliance Across the Product Lifecycle

GxP (Good Practice) principles—GMP (Manufacturing), GLP (Laboratory), and GCP (Clinical)—form the global compliance backbone for life sciences. BQCIS provides independent audits ensuring your operations meet regulatory expectations and remain inspection-ready.

Our certified auditors evaluate your Quality Management System (QMS) for conformity with FDA, EMA, WHO, and ISO 13485 standards. We help clients proactively identify weaknesses, remediate non-conformances, and strengthen QMS maturity to avoid costly regulatory findings.

From Pre-Approval Inspections (PAI) readiness to CAPA system improvement, BQCIS transforms compliance management into a strategic advantage—enhancing data integrity, risk control, and quality culture.

Key GxP Auditing & QMS Services

Supplier, Vendor & Pre-Approval Audits

Audits of API manufacturers, CMOs, and testing labs to verify compliance with cGMP and quality agreements. Includes PAI-readiness audits simulating regulatory inspections, ensuring documentation, training, and facilities meet FDA/EMA expectations before official review.

QMS Remediation & Regulatory Gap Analysis

Post-inspection support and CAPA program design following FDA 483s or Warning Letters. BQCIS identifies systemic failures, defines corrective actions, and implements sustainable quality improvements aligned with global GxP expectations.

Key Benefits of GxP Auditing & Quality Systems

Compliance

Global Compliance Assurance

Aligns operations with current GMP, GLP, and GCP standards across multiple jurisdictions (FDA, EMA, WHO).

Readiness

Audit Readiness & Risk Reduction

Ensures inspection preparedness, reducing regulatory observations and costly post-inspection remediations.

Improvement

Enhanced CAPA Effectiveness

Improves root-cause analysis and corrective-action traceability for measurable, sustainable quality outcomes.

Culture

Strengthened Quality Culture

Transforms compliance into operational excellence through proactive monitoring and continuous improvement.

Success Story

Pre-Approval Audit Prevents Critical FDA Observation

The Challenge:

A mid-sized CMO faced a looming FDA PAI for a new drug facility, with insufficient readiness and data-integrity risks.

Our Solution:

BQCIS performed a full simulation audit focused on Data Integrity, aseptic operations, and documentation flow—identifying critical gaps before the agency inspection.

The Result:

Corrective actions implemented prior to inspection led to zero critical observations and on-time market authorization.

View More Case Studies →